2026 IMS | IASO Bio Presents First-in-Human Phase 1 Data of RD140, a Fully Human BCMA/GPRC5D Dual-Targeted FasT CAR-T
— Poster presentation selected for the poster discussion session (Abstract No.: PA-200): in a first-in-human study in 9 heavily pretreated, high-risk patients with relapsed/refractory multiple myeloma or plasma cell leukemia, RD140, a fully human BCMA/GPRC5D dual-targeted FasT CAR-T,...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Everlight Solar Resolves Nebraska Attorney General Matter
- Aleut Federal Unveils Advanced AV/VTC Collaboration Environment in Colorado Springs
- Steve and Judy Pagliuca and Governor Maura Healey Accelerate Major Effort to Deliver Treatments for Long COVID
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →